Terbinafine and antinuclear antibody positive Patient Reports February 11, 2012

Terbinafine Side Effects Report #5739662-5
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 01, 2008. Male patient, 69 years of age, was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, autoantibody positive, cutaneous lupus erythematosus, rash . Terbinafine dosage: 250 MG;ORAL;1DAY. During the same period patient was treated with ASPIRIN, TAMSULOSIN. Patient recovered.

Terbinafine Side Effects Report #5744917-4
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED STATES on May 01, 2008. Male patient, 69 years of age, was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, autoantibody positive, rash , systemic lupus erythematosus. Terbinafine dosage: 250 MG; 1DAY; ORAL. During the same period patient was treated with ASPIRIN, TAMSULOSIN. Patient recovered.

Terbinafine Side Effects Report #5853452-4
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 04, 2008. Female patient, 64 years of age, was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus. Terbinafine dosage: unknown. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5661105-0
Terbinafine side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Male patient, 57 years of age, was diagnosed with onychomycosis and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, dermatomyositis, dyspnoea, inflammation, muscular weakness, necrosis. Terbinafine dosage: unknown. Patient recovered.


Terbinafine Side Effects Report #5735723-5
Terbinafine side effect was reported by a Health Professional from UNITED KINGDOM on May 01, 2008. Female patient was diagnosed with onychomycosis, cardiovascular disorder, benign prostatic hyperplasia and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, autoantibody positive, cutaneous lupus erythematosus, rash . Terbinafine dosage: 250 MG, UNK. During the same period patient was treated with ASPIRIN, TAMSULOSIN. Patient recovered.

Terbinafine Side Effects Report #5304183-0
Terbinafine side effect was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, 57 years of age, was diagnosed with nail tinea and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, alanine aminotransferase increased, alpha 1 foetoprotein increased, anorexia, antinuclear antibody positive, ascites, aspartate aminotransferase increased, asthenia. Terbinafine dosage: 250 MG, QD. Patient recovered.

Terbinafine Side Effects Report #4689040-5
Terbinafine side effect was reported by a Consumer or non-health professional from on June 06, 2005. Female patient, 46 years of age, was diagnosed with nail tinea and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus, dermatitis bullous, haemolytic anaemia, lymphopenia. Terbinafine dosage: unknown. Patient recovered.

Terbinafine Side Effects Report #4860789-4
Terbinafine side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Nov 05, 2003. Female patient, 39 years of age, was diagnosed with nail tinea, arthritis  and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, arthralgia, double stranded dna antibody, fatigue, histone antibody positive, malaise, myalgia, photosensitivity reaction, rash . Terbinafine dosage: 250 MG/D. During the same period patient was treated with FAMOTIDINE, MELOXICAM. Patient was hospitalized. Patient recovered.

Terbinafine Side Effects Report #5853449-4
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 04, 2008. Female patient was diagnosed with nail infection and was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus. Terbinafine dosage: unknown. Patient recovered.


Terbinafine Side Effects Report #5853451-2
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 04, 2008. Female patient, 46 years of age, was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus. Terbinafine dosage: unknown. Patient recovered.

Terbinafine Side Effects Report #5853448-2
Terbinafine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 04, 2008. Female patient, 43 years of age, was treated with Terbinafine. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cutaneous lupus erythematosus. Terbinafine dosage: unknown. Patient recovered.

Terbinafine Side Effects Report #5491650-2
Terbinafine side effect was reported by a Physician from UNITED STATES on Oct 18, 2007. Female patient, 41 years of age, was treated with Terbinafine. After drug was administered, patient experienced the following side effects: acute hepatic failure, antinuclear antibody positive, autoimmune hepatitis, haemorrhage, international normalised ratio increased, liver disorder, oral herpes. Terbinafine dosage: unknown. During the same period patient was treated with LEVOXYL, PROTONIX, PHENERGAN, ACYCLOVIR, WELLBUTRIN, ECHINACEA. Patient recovered.